E‐cigarette cessation and transitions in combusted tobacco smoking status: longitudinal findings from the US FDA PATH Study
Addiction · 2023
DOI: 10.1111/add.16141 ↗Kurz gefasst
Fachartikel in der Zeitschrift Addiction, 2023. Verfasst von Elias M Klemperer und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Psychological Science, University of Vermont, Burlington, VT, USA. Hauptthemen laut MEDLINE: Electronic Nicotine Delivery Systems, Smoking Cessation, Tobacco Products. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDA NIH HHS, NIGMS NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
Background and Aims Electronic nicotine delivery systems (ENDS) can help people to quit smoking combusted tobacco products (CTPs), but most current and former smokers who use ENDS also intend to quit ENDS. This analysis measured whether ENDS cessation among current and former CTP smokers is associated with changes in CTP smoking or abstinence.
Design
Regression analysis of a nationally representative cohort from waves 4 (W4) and 5 (W5) of the Population Assessment of Tobacco and Health Study (December 2016–November 2019).
Setting
United States.
Participants
Adults ( n = 1525) who reported W4 current or former use of ≥ 1 CTP and either currently using ENDS or quitting ENDS in the past year were included.
Measurements
Logistic regressions were performed separately among W4 current and former CTP smokers, controlling for demographic and tobacco use characteristics. First, we analyzed proximal outcomes by testing the association between ENDS quit status and CTP abstinence, both occurring during W5. Next, we analyzed long‐term outcomes by testing W4 ENDS quit status as a predictor of CTP abstinence at W5, approximately 1 year later.
Findings
Among W4 current CTP smokers, there was no evidence that CTP smoking abstinence differed between those quitting or continuing using ENDS, both in our proximal [adjusted odds ratio (aOR) = 1.37, 95% confidence interval (CI) = 0.90, 2.10] and long‐term (aOR = 0.90, 95% CI = 0.52, 1.53) analyses. Among former CTP smokers, quitting ENDS was associated with less CTP abstinence in our proximal analysis (aOR = 0.42, 95% CI = 0.20, 0.89), but there was no evidence that CTP smoking abstinence differed between those quitting or continuing using ENDS in our long‐term analysis (aOR = 0.86, 95% CI = 0.44, 1.67).
Conclusions
There is no evidence that ENDS cessation is associated with CTP abstinence among current smokers, although mixed findings among former smokers indicate a possible risk for relapse to smoking associated with quitting ENDS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Psychiatry and Psychological Science, University of Vermont, Burlington, VT, USA.
- Department of Biostatistics, University of Vermont, Burlington, VT, USA.
- Department of Public Health Sciences, Medical University of South Carolina, Charleston, SC, USA.
- Department of Pulmonary, Critical Care, Allergy, and Sleep Medicine, Medical University of South Carolina, Charleston, SC, USA.
- Department of Psychiatry and Behavioral Sciences and Hollings Cancer Center, Medical University of South Carolina, Charleston, SC, USA.
ORCID-Profile: Elias M Klemperer, K Michael Cummings, Matthew J Carpenter
Förderung
- NIDA NIH HHS
- NIGMS NIH HHS
- NHLBI NIH HHS
- NIAMS NIH HHS
- NCI NIH HHS
- National Institute of General Medical Sciences
- National Institute on Drug Abuse
- National Cancer Institute
Zitieren
APA
Klemperer, E. M., Bunn, J. Y., Palmer, A. M., Smith, T. T., Toll, B. A., Cummings, K. M., & Carpenter, M. J. (2023). E‐cigarette cessation and transitions in combusted tobacco smoking status: longitudinal findings from the US FDA PATH Study. Addiction. https://doi.org/10.1111/add.16141
Vancouver
Klemperer EM, Bunn JY, Palmer AM, Smith TT, Toll BA, Cummings KM, et al. E‐cigarette cessation and transitions in combusted tobacco smoking status: longitudinal findings from the US FDA PATH Study. Addiction. 2023. doi:10.1111/add.16141
BibTeX
@article{Klemperer2023,
author = {Klemperer, Elias M and Bunn, Janice Y and Palmer, Amanda M and Smith, Tracy T and Toll, Benjamin A and Cummings, K Michael and Carpenter, Matthew J},
title = {E‐cigarette cessation and transitions in combusted tobacco smoking status: longitudinal findings from the US FDA PATH Study},
journal = {Addiction},
year = {2023},
doi = {10.1111/add.16141}
}
EUVIMED